Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced the launch of a study on human adipose derived mesenchymal progenitor cell therapy for Cartilage Defects resulting from osteoarthritis or sports injury.
http://ift.tt/1ustiVF
http://ift.tt/1ustiVF
No comments:
Post a Comment